Evotec OAI makes further progress
Evotec BioSystems continues its expansion as planned during the first half of 2001. The company achieved revenues of €26.3m, an increase of 311% over the respective period in 2000. This strong increase over the year can be attributed to the acquisition of the chemistry business late in 2000 and good growth in biology services.